UK markets open in 59 minutes

Catalent Inc (0C8.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
50.30+0.92 (+1.87%)
As of 08:01AM CEST. Market open.
Full screen
Previous close49.38
Open50.30
Bid50.86 x 0
Ask51.03 x 0
Day's range50.30 - 50.30
52-week range30.80 - 55.50
Volume25
Avg. volume0
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Catalent Stockholders Approve Transaction with Novo Holdings

    SOMERSET, N.J., May 29, 2024--Catalent, Inc. ("Catalent," NYSE: CTLT), a leader in enabling the development and supply of better treatments for patients worldwide, today announced that, at its Special Meeting of Stockholders (the "Special Meeting") held earlier today, its stockholders voted to approve the pending transaction under which Novo Holdings A/S ("Novo Holdings") will acquire all outstanding shares of Catalent for $63.50 per share in cash (the "Merger").

  • Business Wire

    Catalent, Inc. Reports Third Quarter Fiscal 2024 Results

    SOMERSET, N.J., May 08, 2024--Catalent, Inc. (NYSE: CTLT) ("Catalent"), the leader in enabling the development and supply of better treatments for patients worldwide, today announced financial results for the third quarter of fiscal 2024, which ended March 31, 2024.

  • Business Wire

    Catalent Publishes Fifth Annual Corporate Responsibility Report, Highlighting Progress and Reinforcing Long-Term Commitment

    SOMERSET, N.J., March 07, 2024--Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, has today published its fiscal 2023 Corporate Responsibility Report, highlighting positive progress across every pillar of Catalent’s corporate responsibility strategy – People, Environment, and Community. The report also outlines the company’s future commitments as it progresses its mission to help people lead better and healthier lives.